News for '-rct'

How Banerjee-Duflo's economic theory is relevant for India

How Banerjee-Duflo's economic theory is relevant for India

Rediff.com15 Oct 2019

For Duflo and Banerjee, an important part of their work has been ensuring that the agency of the "beneficiaries" -- usually, in developing countries like India, poorer individuals -- is put at the centre of any policy design. This is a crucial way in which experimental results are often better than large scale data-based inference, says Mihir S Sharma.

Mixing Covishield, Covaxin shows better immunogenicity: ICMR study

Mixing Covishield, Covaxin shows better immunogenicity: ICMR study

Rediff.com8 Aug 2021

The study titled 'Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime' has been uploaded on medRxiv, a preprint server and is yet to be peer reviewed.

Experts welcome WHO's decision to resume HCQ clinical trial

Experts welcome WHO's decision to resume HCQ clinical trial

Rediff.com4 Jun 2020

The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.

Banerjee-Duflo duo and Bandhan Bank's anti-poverty scheme

Banerjee-Duflo duo and Bandhan Bank's anti-poverty scheme

Rediff.com16 Oct 2019

According to a 2011 impact assessment study of the programme by Banerjee and Duflo, along with economists Raghabendra Chattopadhyay and Jeremy Shapiro, Bandhan's THP results in a 15 per cent increase in household consumption and had a positive impact on wealth and welfare, such as assets and emotional well being.

'India might not have a third wave'

'India might not have a third wave'

Rediff.com6 Oct 2021

'Between its natural immunity with Delta, in so many populations, and then getting on top of the vaccination (situation), I do not think India is going to have another bad wave.'

Abhijit Banerjee and the mystique of the Nobel Prize

Abhijit Banerjee and the mystique of the Nobel Prize

Rediff.com2 Nov 2019

Does Abhijit Banerjee's Nobel Prize help India reduce extreme poverty, asks Rajeev Srinivasan.

Ramdev's Patanjali claims to have COVID-19 medicine; Govt frowns

Ramdev's Patanjali claims to have COVID-19 medicine; Govt frowns

Rediff.com23 Jun 2020

While Ramdev claimed that Ayurved-based 'Coronil and Swasari' medicine have shown 100 per cent favourable results during clinical trials on COVID-19 infected patients except those on a life support system, the Ayush Ministry sought from the company detailed report on composition, testing and other data of the drugs.

India and the economics of good intentions

India and the economics of good intentions

Rediff.com14 Nov 2019

Good intentions are best left to political parties, governments and religious establishments, suggests T C A Srinivasa-Raghavan.

COVID-19: The threat from people with no symptoms

COVID-19: The threat from people with no symptoms

Rediff.com14 May 2020

'Testing is a very good strategy if only symptomatic people are transmitting the disease.' 'Here asymptomatic people, with minimum, trivial symptoms, are transmitting too.' 'Testing, treating, tracing contacts and quarantining them -- yes, it will work up to a certain extent.' 'But more important is physical distancing, hand hygiene, cough etiquette and cocooning, protecting with reverse quarantining the most vulnerable people, senior citizens, people with other major medical problems.' 'To me, that makes much more sense.'